tetano
Editor, Senior Moderator
Am J Med
. 2024 Mar 12:S0002-9343(24)00133-5.
doi: 10.1016/j.amjmed.2024.02.029. Online ahead of print. A Critical Review on the Long-term COVID-19 Impacts on Patients with Diabetes
Sumel Ashique[SUP] 1 [/SUP], Neeraj Mishra[SUP] 2 [/SUP], Ashish Garg[SUP] 3 [/SUP], Sweta Garg[SUP] 4 [/SUP], Arshad Farid[SUP] 5 [/SUP], Shweta Rai[SUP] 6 [/SUP], Gaurav Gupta[SUP] 7 [/SUP], Dua Kamal[SUP] 8 [/SUP], Keshav Raj Paudel[SUP] 9 [/SUP], Farzad Taghizadeh-Hesary[SUP] 10 [/SUP]
Affiliations
Background: The world is currently grappling with the potentially life-threatening coronavirus disease 2019 (COVID-19), marking it as the most severe health crisis in the modern era. COVID-19 has led to a pandemic, with the World Health Organization (WHO) predicting that individuals with diabetes are at a higher risk of contracting the virus compared to the general population. This review aims to provide a practical summary of the long-term impacts of COVID-19 on patients with diabetes. Specifically, it focuses on the effects of SARS-CoV-2 on different types of diabetic patients, the associated mortality rate, the underlying mechanisms, related complications, and the role of vitamin D and zinc in therapeutic and preventive approaches.
Methods: Relevant literature was identified through searches on PubMed, Web of Science, and Science Direct in English, up to April 2023.
Results: COVID-19 can lead to distressing symptoms and pose a significant challenge for individuals living with diabetes. Older individuals and those with pre-existing conditions such as diabetes, coronary illness, and asthma are more susceptible to COVID-19 infection. Managing COVID-19 in individuals with diabetes presents challenges, as it not only complicates the fight against the infection but also potentially prolongs the recovery time. Moreover, the virus may thrive in individuals with high blood glucose levels. Various therapeutic approaches, including anti-diabetic drugs, are available to help prevent COVID-19 in diabetic patients.
Conclusions: Diabetes increases the morbidity and mortality risk for patients with COVID-19. Efforts are globally underway to explore therapeutic interventions aimed at reducing the impact of diabetes on COVID-19.
Keywords: Diabetes mellitus; Morbidity; Mortality; Treatment; long-term COVID-19.
. 2024 Mar 12:S0002-9343(24)00133-5.
doi: 10.1016/j.amjmed.2024.02.029. Online ahead of print. A Critical Review on the Long-term COVID-19 Impacts on Patients with Diabetes
Sumel Ashique[SUP] 1 [/SUP], Neeraj Mishra[SUP] 2 [/SUP], Ashish Garg[SUP] 3 [/SUP], Sweta Garg[SUP] 4 [/SUP], Arshad Farid[SUP] 5 [/SUP], Shweta Rai[SUP] 6 [/SUP], Gaurav Gupta[SUP] 7 [/SUP], Dua Kamal[SUP] 8 [/SUP], Keshav Raj Paudel[SUP] 9 [/SUP], Farzad Taghizadeh-Hesary[SUP] 10 [/SUP]
Affiliations
- PMID: 38485111
- DOI: 10.1016/j.amjmed.2024.02.029
Background: The world is currently grappling with the potentially life-threatening coronavirus disease 2019 (COVID-19), marking it as the most severe health crisis in the modern era. COVID-19 has led to a pandemic, with the World Health Organization (WHO) predicting that individuals with diabetes are at a higher risk of contracting the virus compared to the general population. This review aims to provide a practical summary of the long-term impacts of COVID-19 on patients with diabetes. Specifically, it focuses on the effects of SARS-CoV-2 on different types of diabetic patients, the associated mortality rate, the underlying mechanisms, related complications, and the role of vitamin D and zinc in therapeutic and preventive approaches.
Methods: Relevant literature was identified through searches on PubMed, Web of Science, and Science Direct in English, up to April 2023.
Results: COVID-19 can lead to distressing symptoms and pose a significant challenge for individuals living with diabetes. Older individuals and those with pre-existing conditions such as diabetes, coronary illness, and asthma are more susceptible to COVID-19 infection. Managing COVID-19 in individuals with diabetes presents challenges, as it not only complicates the fight against the infection but also potentially prolongs the recovery time. Moreover, the virus may thrive in individuals with high blood glucose levels. Various therapeutic approaches, including anti-diabetic drugs, are available to help prevent COVID-19 in diabetic patients.
Conclusions: Diabetes increases the morbidity and mortality risk for patients with COVID-19. Efforts are globally underway to explore therapeutic interventions aimed at reducing the impact of diabetes on COVID-19.
Keywords: Diabetes mellitus; Morbidity; Mortality; Treatment; long-term COVID-19.
